Autoimmune Disease Diagnosis Market To Reach USD 7.37 Billion By 2027 – Top Key Players Siemens, Danaher, Thermo Fisher Scientific

The elevating incidence rate of autoimmune diseases across the globe and the growing number of researches on autoimmune disease diagnosis are boosting the market demand.
The global Autoimmune Disease Diagnosis Market is forecast to reach USD 7.37 Billion by 2027, according to a new report by Reports and Data. An increase in awareness of the autoimmune disease through education, research, and advocacy will drive the market demand.

A condition in which one’s immune system mistakenly attacks your body, it is known as an autoimmune disease. Normally, the immune system generally guards the body against foreign invaders, but when one has this disease, the immune system mistakes a part of the body as foreign and starts attacking healthy cells.

Multiple Sclerosis is a disabling condition of the central nervous system that impairs the flow of information within the brain and between the body and the brain. Increasing research related to the signs and treatments related to the disease is expected to drive the market growth. Another challenge faced by the Multiple Sclerosis therapeutics market is the lack of awareness among the people associated with the Multiple Sclerosis condition. The demand for Multiple Sclerosis is expected to increase owing to the new drug developments for treating Multiple Sclerosis, which in turn will drive the demand for the autoimmune disease diagnosis market.

The COVID-19 impact:

One of the major impacts of COVID-19 on the market has been elevated demand for point-of-care immunodiagnostic tests. The development of these easy-to-use and rapid devices to support testing outside of laboratory settings has been a response of diagnostic test manufacturers to shortages of laboratory-based molecular testing capacity. The increasing focus on large screen testing for COVID-19 has led to a shortage in the supply for diagnostic kits for autoimmune diseases. Diagnostic companies are under immense pressure to provide reliable point-of-care testing capacities

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3436

Technological advancements and rapid digitization have streamlined the daily operations of the pharmaceutical industry. Increasing spending on medicine due to growing geriatric populace, rising incidence of chronic diseases, increasing number of product launches, and growing number of R&D activities are some key factors contributing to revenue growth of the market. Increasing focus on patient engagement solutions, rising focus to cater to growing unmet clinical demand, adoption of advanced technologies to streamline workflows in healthcare sector, and availability of skilled healthcare professionals has been positively impacting the pharma & healthcare industry. The emergence of COVID-19 pandemic has further increased focus on healthcare facilities, teleconsultation and telemedicine, and increased burden on the healthcare industry compelling governments and companies to invest heavily to cater to the growing global demand.

Further key findings from the report suggest

• Consumables and Assay Kits dominated the market for autoimmune disease diagnostic and is forecasted to grow with a CAGR of 8.2% during the forecast period. The segment is driven by an increasing need for rapid diagnosis of autoimmune disease.

• Rheumatoid arthritis is an inflammatory disease that affects the joints. The condition worsens over time unless the inflammation is slowed or stopped. The disease rarely goes into remission without treatment. Statistics show that out of every 100,000 people, 41 are diagnosed with RA every year. Women are about 2-3 times more likely to get RA than men. Hormones in both genders may play a role in either preventing or triggering it.

• Hospital pharmacies are expected to hold a larger market share owing to an increase in the autoimmune disease consultations in clinics and hospitals. The prolonged use of these medications can lead to drug resistance, which compels the patients to refer to a rheumatologist and follow guided therapies. Moreover, the number of OTC Drugs available for treatment is insufficient, which, in turn, is further propelling the growth of this segment.

• The market in Asia-Pacific is anticipated to witness high growth during the forecast period owing to the increasing healthcare expenditure. Furthermore, the low cost of manufacturing in India and China has resulted in an increase in the production facilities, which attracts pharmaceutical and biotechnological giants to the region.

• Key participants include Siemens, Danaher, Thermo Fisher Scientific, Grifols, Abbott, Bio-Rad Laboratories, Werfen, Trinity Biotech, Hycor Biomedical, and Euroimmun, among others.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3436

For the purpose of this report, Reports and Data have segmented the global Autoimmune Disease Diagnosis Market on the basis of Product, Test Type, Disease, End User, and region:

Product Outlook (Revenue, USD Billion; 2017-2027)

• Instruments
• Consumables and Assay Kits

Test Type Outlook (Revenue, USD Billion; 2017-2027)

• Inflammatory markers
• Routine laboratory tests
• Autoantibodies and immunologic tests
• Others tests

Disease Outlook (Revenue, USD Billion; 2017-2027)

• Systemic Lupus Erythematosus
• Thyroiditis
• Rheumatoid Arthritis
• Sjögren’s Syndrome
• Scleroderma
• Others

End-User Outlook (Revenue, USD Billion; 2017-2027)

• Hospitals
• Clinical Laboratories
• Other

Regional Outlook (Revenue, USD Billion; 2017-2027)

• North America
o U.S
o Canada
• Europe
o Germany
o U.K
o France
o BENELUX
o Rest of Europe
• Asia Pacific
o China
o Japan
o South Korea
o Rest of APAC
• Latin America
o Brazil
o Rest of LATAM
• MEA
o Saudi Arabia
o UAE
o Rest of MEA

In conclusion, the report offers a comprehensive analysis of the factors expected to drive the global Autoimmune Disease Diagnosis market growth over the forecast period of 2021-2028. The report is an all-inclusive document covering the market landscape and a futuristic perspective on its growth and progress. The report also provides an analysis of the entry-level driving and restraining factors for the new entrants contributing to the market. The report also offers strategic recommendations to the established players as well as new entrants to help them gain a strong foothold in the market.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3436

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.

Read More Reports:-

Gene Expression Market @ https://www.google.kz/url?q=https://www.reportsanddata.com/report-detail/gene-expression-market

Pressure Monitoring Market @ https://www.google.co.zw/url?q=https://www.reportsanddata.com/report-detail/pressure-monitoring-market

Phototherapy Market @ https://www.google.bf/url?q=https://www.reportsanddata.com/report-detail/phototherapy-market

Contact Us:

John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.